Most cited papers from Jose Pearson TB Hospital
What are the most cited papers from Jose Pearson TB Hospital?
The most cited paper from Jose Pearson TB Hospital is "The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis" (Andreas Henri Diacon et al., 2009), with 846 citations. Next come "Linezolid resistance in patients with drug-resistant TB and treatment failure in South Africa" (62) and "Extensively Drug-Resistant TB in Eastern Cape, South Africa: High Mortality in HIV-Negative and HIV-Positive Patients" (56).
Showing 11 of 11 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis Andreas Henri Diacon et al. · New England Journal of Medicine | 3 Jun 2009 | 846 |
| 2 | Linezolid resistance in patients with drug-resistant TB and treatment failure in South Africa Sean A Wasserman, Gail Louw, Limpho Ramangoaela et al. · Journal of Antimicrobial Chemotherapy | 16 Apr 2019 | 62 |
| 3 | Extensively Drug-Resistant TB in Eastern Cape, South Africa: High Mortality in HIV-Negative and HIV-Positive Patients Charlotte Kvasnovsky, J. Peter Cegielski, Roshen Erasmus et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes | 5 Feb 2011 | 56 |
| 4 | Effectiveness and Cardiac Safety of Bedaquiline-Based Therapy for Drug-Resistant Tuberculosis: A Prospective Cohort Study James C.M. Brust et al. · Clinical Infectious Diseases | 17 Apr 2021 | 49 |
| 5 | Adverse effects of bedaquiline in patients with extensively drug-resistant tuberculosis Razia Gaida, Ilse Truter, Charles Adams Peters · Southern African Journal of Infectious Diseases | 14 Oct 2020 | 24 |
| 6 | Prevention care cascade in people exposed to drug-resistant TB Brittney J. van de Water, Ashlee J. Vance, Limpho Ramangoaela et al. · The International Journal of Tuberculosis and Lung Disease | Dec 2020 | 12 |
| 7 | Triage test for all-oral drug-resistant tuberculosis (DR-TB) regimen: a phase IV study to assess effectiveness, feasibility, acceptability and cost-effectiveness of the Xpert MTB/XDR assay for rapid triage and treatment of DR-TB Kogieleum Naidoo et al. · BMJ Open | Nov 2024 | 7 |
| 8 | The Effect of HIV and Antiretroviral Therapy on Drug-Resistant Tuberculosis Treatment Outcomes in Eastern Cape, South Africa: A Cohort Study Brittney J. van de Water, Nadia N. Abuelezam, Jenny Hotchkiss et al. · Viruses | 10 Nov 2023 | 5 |
| 9 | Factors Influencing Web 2.0 Technology Usage Among Academics Indira Padayachee, Kebashnee Moodley · International Journal of Technology and Human Interaction | 23 Dec 2021 | 5 |
| 10 | Risk factors for and timing of presumptive recurrent TB A.N. Shapiro, Lesley Erica Scott, Harry Moultrie et al. · The International Journal of Tuberculosis and Lung Disease | 29 Oct 2024 | 2 |
| 11 | A Retrospective Analysis Examining the Impact of Educational Attainment and Social Determinants of Health on Rifampicin-Resistant Tuberculosis Treatment Outcomes Titilade Kehinde Ayandeyi Teibo, Rubeshan Perumal, Lateef Babatunde Amusa et al. · Open Forum Infectious Diseases | 19 Aug 2026 | 0 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.